Regulatory and Economic Aspects in Oncology
Topics:
Cost of Cancer: Healthcare Expenditures and Economic Impact
Oncology from an HTA and Health Economic Perspective
Heterogeneous Recommendations for Oncology Products Among Different HTA Systems: A Comparative Assessment
Patient-Reported Outcomes in Oncology, Beyond Randomized Controlled Trials
Patient-Reported Outcomes in Health Economic Decision-Making: A Changing Landscape in Oncology
Approaches to Capturing Value in Oncology
Orphan Drugs in Oncology
Recent Developments in Health Economic Modelling of Cancer Therapies
Drug Pricing and Value in Oncology
Regulatory and Evidence Requirements and the Changing Landscape in Regulation for Marketing Authorisation
Prioritization not Rationing in Cancer Care
